Yttrium-90 radioembolization is a minimally invasive treatment that may slow disease progression in breast cancer that has metastasized to the liver.
Early progress has been made in developing a treatment that might one day help the immune system defend itself against cancer, but research is still in preliminary stages.
Meta-analysis of 13 randomized controlled trials shows small but significant effect from the patient-clinician relationship.
Nearly half of patients with the most common form of adult leukemia may have a distinct pattern of genetic abnormalities that could better define their prognosis and treatment.
A new European study does not support administration of intensified doxorubicin and ifosfamide for palliation of advanced soft tissue sarcoma.
Many Americans paying less for prescription drugs, but some are having to deal with sharp rises in cost of specialty meds.
The author prided herself on her professional nursing skills. But a trip to the other side of the nurse-patient relationship changed how she provides care.
A gene not previously associated with breast cancer appears to play a pivotal role in the growth and progression of triple-negative breast cancer.
Interval cancers more likely to be earlier stage, proximal, have lower risk of death
Two studies provide new insight into a germline epidermal growth factor receptor T790M mutation in familial non-small cell lung cancer, and suggest the need for tailored approaches for early detection and treatment.
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|